Idiopathic Intracranial Hypertension Clinical Trial
Official title:
Evaluating Raised Intracranial Pressure Using MR Elastography
Investigators will compare magnetic resonance (MR) elastography measurements to other forms of noninvasive methods of detecting raised intracranial pressure, including optical coherence tomography (OCT) imaging measurements of the retinal nerve fiber layer (RNFL) and indirect signs of raised intracranial pressure on magnetic resonance imaging (MRI).
Status | Recruiting |
Enrollment | 200 |
Est. completion date | December 2025 |
Est. primary completion date | December 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | All subjects will have the following inclusion criteria: - Group 1: Papilledema from idiopathic intracranial hypertension and other forms of elevated intracranial pressure, including obstructive hydrocephalus - Group 2: Patients without raised intracranial pressure. All subjects will have the following exclusion criteria: - Age <18 - Pregnancy (self-reported) - Individuals for whom MR is contraindicated |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic in Rochester | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic | National Eye Institute (NEI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | MR elastography measurement of the brain elasticity | The primary outcome measure is the difference in the brain elasticity on MR elastography between patients with raised intracranial pressure and those with normal intracranial pressure | 1-2 weeks prior to lumbar puncture | |
Secondary | MRI finding | The secondary outcome measurement are the retinal nerve fiber layer (RNFL) thickness and Bruch's membrane configuration on the MRI findings of raised intracranial pressure (optic nerve sheath diameter and pituitary/sella ratio). The cutoff from abnormal-to-normal will be established. The sensitivity and specificities will be established and compared against the other secondary outcome measurements and against MR elastography. | 1--2 weeks prior to lumbar puncture | |
Secondary | Ocular Coherence Tomography (OCT) finding | The secondary outcome measurements are the retinal nerve fiber layer (RNFL) thickness and Bruch's membrane configuration using ocular coherence tomography (OCT) of raised intracranial pressure (optic nerve sheath diameter and pituitary/sella ratio). The cutoff from abnormal-to-normal will be established. The sensitivity and specificities will be established and compared against the other secondary outcome measurements and against MR elastography | 1--2 weeks prior to lumbar puncture | |
Secondary | Optic Nerve B-scan ultrasound finding | The secondary outcome measurement are the retinal nerve fiber layer (RNFL) thickness and Bruch's membrane configuration on the optic nerve B-scan ultrasound findings of raised intracranial pressure (optic nerve sheath diameter and pituitary/sella ratio). The cutoff from abnormal-to-normal will be established. The sensitivity and specificities will be established and compared against the other secondary outcome measurements and against MR elastography. | 1--2 weeks prior to lumbar puncture |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01863381 -
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
|
N/A | |
Recruiting |
NCT06027567 -
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
|
Phase 4 | |
Active, not recruiting |
NCT02896452 -
Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
|
||
Recruiting |
NCT06059703 -
Biomarkers in the Etiology of Idiopathic Intracranial Hypertension
|
N/A | |
Terminated |
NCT05347147 -
A Trial to Determine the Efficacy and Safety of Presendin in IIH
|
Phase 3 | |
Not yet recruiting |
NCT06361823 -
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
|
Phase 3 | |
Active, not recruiting |
NCT02124486 -
An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIH
|
N/A | |
Recruiting |
NCT02143258 -
Stenting of Venous Sinus Stenosis for Medically Refractory Idiopathic Intracranial Hypertension
|
N/A | |
Enrolling by invitation |
NCT05308823 -
Outcome of Cerebral Venous Sinuses Stenting on Idiopathic Intracranial Hypertension
|
N/A | |
Not yet recruiting |
NCT05762367 -
MR Lymphatic Imaging in Idiopathic Intracranial Hypertention
|
N/A | |
Not yet recruiting |
NCT06436820 -
ICP & Outflow Study
|
||
Completed |
NCT03867461 -
The Effects of MAP and EtCO2 on Venous Sinus Pressures
|
N/A | |
Completed |
NCT03963336 -
Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension
|
Early Phase 1 | |
Completed |
NCT01003639 -
Idiopathic Intracranial Hypertension Treatment Trial
|
Phase 2/Phase 3 | |
Completed |
NCT04314128 -
Assessment of ICP in Idiopathic Intracranial Hypertension Using Transocular Ultrasound and Transcranial Doppler
|
N/A | |
Terminated |
NCT03501966 -
Surgical Idiopathic Intracranial Hypertension Treatment Trial
|
Phase 3 | |
Active, not recruiting |
NCT03556085 -
Venous Sinus Stenting With the River Stent in IIH
|
N/A | |
Completed |
NCT02017444 -
Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
|
Phase 2 |